期刊文献+

Advances in endoscopic retrograde cholangiopancreatography for the treatment of cholangiocarcinoma 被引量:19

Advances in endoscopic retrograde cholangiopancreatography for the treatment of cholangiocarcinoma
下载PDF
导出
摘要 Cholangiocarcinoma(CCA) is a malignancy of the bileducts that carries high morbidity and mortality. Patients with CCA typically present with obstructive jaundice, and associated complications of CCA include cholangitis and biliary sepsis. Endoscopic retrograde cholangiopancreatography(ERCP) is a valuable treatment modality for patients with CCA, as it enables internal drainage of blocked bile ducts and hepatic segments by using plastic or metal stents. While there remains debate as to if bilateral(or multi-segmental) hepatic drainage is required and/or superior to unilateral drainage, the underlying tenant of draining any persistently opacified bile ducts is paramount to good ERCP practice and good clinical outcomes. Endoscopic therapy for malignant biliary strictures from CCA has advanced to include ablative therapies via ERCP-directed photodynamic therapy(PDT) or radiofrequency ablation(RFA). While ERCP techniques cannot cure CCA, advancements in the field of ERCP have enabled us to improve upon the quality of life of patients with inoperable and incurable disease. ERCP-directed PDT has been used in lieu of brachytherapy to provide neoadjuvant local tumor control in patients with CCA who are awaiting liver transplantation. Lastly, mounting evidence suggests that palliative ERCP-directed PDT, and probably ERCPdirected RFA as well, offer a survival advantage to patients with this difficult-to-treat malignancy. Cholangiocarcinoma (CCA) is a malignancy of the bileducts that carries high morbidity and mortality. Patientswith CCA typically present with obstructive jaundice,and associated complications of CCA include cholangitisand biliary sepsis. Endoscopic retrograde cholangiopancreatography(ERCP) is a valuable treatment modalityfor patients with CCA, as it enables internal drainageof blocked bile ducts and hepatic segments by usingplastic or metal stents. While there remains debate asto if bilateral (or multi-segmental) hepatic drainageis required and/or superior to unilateral drainage, theunderlying tenant of draining any persistently opacifiedbile ducts is paramount to good ERCP practice and goodclinical outcomes. Endoscopic therapy for malignantbiliary strictures from CCA has advanced to includeablative therapies via ERCP-directed photodynamictherapy (PDT) or radiofrequency ablation (RFA). WhileERCP techniques cannot cure CCA, advancements inthe field of ERCP have enabled us to improve upon thequality of life of patients with inoperable and incurabledisease. ERCP-directed PDT has been used in lieu ofbrachytherapy to provide neoadjuvant local tumorcontrol in patients with CCA who are awaiting livertransplantation. Lastly, mounting evidence suggeststhat palliative ERCP-directed PDT, and probably ERCPdirectedRFA as well, offer a survival advantage topatients with this difficult-to-treat malignancy.
出处 《World Journal of Gastrointestinal Endoscopy》 CAS 2015年第7期675-687,共13页 世界胃肠内镜杂志(英文版)(电子版)
关键词 内视镜后退 cholangiopancreatography CHOLANGIOCARCINOMA STENTS 自我可扩充的金属 stents 光力学的治疗 光力学的治疗 Radiofrequency 脱离 Radiofrequency 脱离 Endoscopic retrograde cholangiopancreatography Cholangiocarcinoma Stents Self-expandablemetal stents Photodynamic therapy Photodynamictherapy Radiofrequency ablation Radiofrequencyablation
  • 相关文献

参考文献4

二级参考文献69

  • 1The Liver Cancer Study Group of Primary. Japan liver cancer in Japan. Cancer 1984; 54:1747-1755.
  • 2Yamamoto J, Kosuge T, Takayama T, Shimada K, Makuuchi M,Yoshida J, Sakamoto M, Hirohashi S, Yamasaki S, Hasegawa H.Surgical treatment of intrahepatic cholangiocarcinoma: four patients surviving more than five years. Surgery 1992; 111:617-622.
  • 3Lieser MJ, Barry MK, Rowland C, Ilstrup DM, Nagorney DM.Surgical management of intrahepatic cholangiocarcinoma: a 31-year experience. ] Hepatobiliarv Pancreat Surg 1998; 5:41-47.
  • 4Chu KM, Lai EC, A1-Hadeedi S, Arcilla CE Jr, Lo CM, Liu CL,Fan ST, Wong J. Intrahepatic cholangiocarcinoma. World J Surg 1997; 21:301-305.
  • 5Goldstein RM, Stone M, Tillery GW, Senzer N, Levy M, Husberg BS, Gonwa T, Klintmalm G. Is liver transplantation indicated for cholan~iocarcinoma? Am I Surg 1993; 166:768-771.
  • 6Pichlmayr-R, Lamesch P, Weimann A, Tusch G, Ringe B. Surgical treatment of cholangiocellular carcinoma. World J Surg 1995; 19:83-88.
  • 7Shimoda M, Farmer DG, Colquhoun SD, Rosove M, Ghobrial RM, Yersiz H, Chen P, Busuttil RW. Liver transplantation for cholangiocellular carcinoma: analysis of a single-center experience and review of the literature. Liver Transpl 2001; 7:1023-1033.
  • 8Curley SA, Izzo F. Radiofrequency ablation of primary and metastic liver tumors. Surg Technol lnt 2002; 10:99-106.
  • 9Livraghi T, Solbiati L, Meloni MF, Gazelle GS, Halpern EF,Goldberg SN. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology 2003; 226:441-451.
  • 10Maluf D, Fisher RA, Maroney T, Cotterell A, Fulcher A, Tisnado J, Contos M, Luketic V, Stravitz R, Shiffman M, Sterling R,Posner M. Non-resective ablation and liver transplantation in patients with cirrhosis and hepatocellular carcinoma (HCC):safety and efficacy. Am J Transplant 2003; 3:312-317.

共引文献47

同被引文献135

引证文献19

二级引证文献428

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部